Luiza Akria

568 total citations
30 papers, 296 citations indexed

About

Luiza Akria is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Luiza Akria has authored 30 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Luiza Akria's work include Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Luiza Akria is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Luiza Akria collaborates with scholars based in Israel, Australia and Spain. Luiza Akria's co-authors include Andrei Braester, Eldad J. Dann, Tsila Zuckerman, Najib Dally, Wojciech Jurczak, Peijuan Zhu, I. Oren, Angela Zubel, Juliana Pereira and H. Sprecher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luiza Akria

30 papers receiving 292 citations

Peers

Countries citing papers authored by Luiza Akria

Since Specialization

Citations

This map shows the geographic impact of Luiza Akria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luiza Akria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luiza Akria more than expected).

Fields of papers citing papers by Luiza Akria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luiza Akria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luiza Akria. The network helps show where Luiza Akria may publish in the future.

Co-authorship network of co-authors of Luiza Akria

This figure shows the co-authorship network connecting the top 25 collaborators of Luiza Akria. A scholar is included among the top collaborators of Luiza Akria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luiza Akria. Luiza Akria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case Report: Anti-platelet factor 4 -mediated immunothrombosis in a patient with ANCA vasculitis – a shared mechanism of NETosis 2025 ·Frontiers in Immunology ·(unknown), (unknown), Luiza Akria, Etty Kruzel-Davila	1
2	The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis 2023 ·International Journal of Laboratory Hematology ·(unknown), Andrei Braester, (unknown), Najib Dally, Luiza Akria, (unknown), (unknown), Igor Waksman	4
3	Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature 2023 ·Taiwanese Journal of Obstetrics and Gynecology ·Maya Frank Wolf, (unknown), Luiza Akria, Eli Rimon, Yifat Wiener, (unknown), (unknown)	4
4	The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients 2022 ·SHILAP Revista de lepidopterología ·Joshua Aviram, Gil M. Lewitus, (unknown), (unknown), (unknown), (unknown), Idan Cohen, Anca Leibovici, Luiza Akria, (unknown), (unknown), (unknown), Ayelet Shai, Gil Bar‐Sela, David Meiri	18
5	Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy 2021 ·Palliative Medicine ·Liza Barki‐Harrington, Orna Baron‐Epel, Adir Shaulov, Luiza Akria, (unknown), Najib Dally, (unknown), (unknown), Maya Koren‐Michowitz, Merav Leiba, (unknown), Lev Shvidel, Tamar Tadmor, (unknown), Miri Zektser, Meir Preis, (unknown), Vered Yahalom, Ariel Aviv	6
6	Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse 2021 ·Acta Haematologica ·Andrei Braester, Ety Shaoul, (unknown), Luiza Akria, (unknown), (unknown)	4
7	Blood Myths and Ethnic–Cultural Background as Impediments in Patient Blood Management Education 2020 ·Journal of Religion and Health ·Andrei Braester, Luiza Akria, (unknown), (unknown), (unknown)	1
8	BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study 2019 ·Blood Advances ·Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren‐Michowitz, Ron Hoffman, Israel Henig, Noa Lavi, Yishai Ofran, Netanel A. Horowitz, (unknown), Sigal Tavor, (unknown), Stela Gengrinovitch, Liat Flaishon, Shoshi Tessler, (unknown), Jacob M. Rowe	10
9	Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation 2018 ·Experimental Hematology ·David Azoulay, Yair Herishanu, (unknown), (unknown), (unknown), Luiza Akria, Andrei Braester	8
10	Physicians’ lack of knowledge - a possible reason for red blood cell transfusion overuse? 2017 ·Israel Journal of Health Policy Research ·(unknown), (unknown), (unknown), Luiza Akria, (unknown), Andrei Braester	11
11	Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study 2017 ·Annals of Oncology ·Wojciech Jurczak, (unknown), (unknown), (unknown), (unknown), (unknown), Nelson Castro, Juliana Pereira, Luiza Akria, (unknown), Dzhelil Osmanov, Peijuan Zhu, (unknown), Angela Zubel, (unknown), (unknown)	3
12	Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients 2017 ·British Journal of Haematology ·Eldad J. Dann, Osnat Bairey, Rachel Bar‐Shalom, Tanya Mashiach, (unknown), Abraham Kornberg, Luiza Akria, Tamar Tadmor, Kalman Filanovsky, Uri Abadi, Olga Kagna, Rosa Ruchlemer, Roxolyana Abdah‐Bortnyak, Neta Goldschmidt, Ron Epelbaum, Netanel A. Horowitz, David Lavie, Dina Ben‐Yehuda, Ofer Shpilberg, Ora Paltiel	26
13	Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study 2017 ·The Lancet Haematology ·Wojciech Jurczak, (unknown), (unknown), (unknown), (unknown), Pratyush Giri, Nelson Castro, Juliana Pereira, Luiza Akria, (unknown), (unknown), Peijuan Zhu, (unknown), Angela Zubel, (unknown), (unknown)	62
14	Astarabine, a Novel Leukemia-Targeted Cytarabine Composition Allows, for the First Time, the Delivery of High Cytarabine Doses for Older or Unfit Patients with Acute Leukemia. Results of an Ongoing Phase I/IIa Study 2016 ·Blood ·Tsila Zuckerman, Stela Gengrinovitch, (unknown), Ron Hoffman, Israel Henig, Noa Lavi, Luiza Akria, Yishai Ofran, Netanel A. Horowitz, (unknown), Maya Koren‐Michowitz, (unknown), Martin S. Tallman, Jacob M. Rowe	2
15	Alterations in Platelet Levels of Brain-Derived Neurotrophic Factor Are Associated with Clinical Response to Bortezomib in Patients with Multiple Myeloma 2014 ·Blood ·David Azoulay, (unknown), Luiza Akria, Netanel A. Horowitz, Andrei Braester	4
16	Alemtuzumab and Myelodysplasia: A Story of Love and Hate (Possible Alemtuzumab-Induced Myelodysplastic Changes) 2012 ·Acta Haematologica ·Andrei Braester, Luiza Akria, (unknown), (unknown)	1
17	Rare coexistence of Rosai–Dorfman disease and nodal marginal zone lymphoma complicated by severe life-threatening autoimmune hemolytic anemia 2012 ·Leukemia & lymphoma ·Luiza Akria, (unknown), Andrei Braester, Hector Cohen, (unknown), Aaron Polliack	14
18	A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients 2006 ·Bone Marrow Transplantation ·I. Oren, (unknown), H. Sprecher, Ada Tamir, Noam Benyamini, Luiza Akria, Alexandra Gorelik, Najib Dally, Tsila Zuckerman, (unknown), Riva Fineman, Eldad J. Dann	46
19	Allogeneic Stem Cell Transplantation (ASCT) in CML with Partial T-Cell Depletion, No Prophylaxis for Graft-Versus-Host Disease (GvHD) and Preemptive DLI for Patients with Post-Transplant Minimal Residual Disease (MRD): An Alternative Approach in CML Transplantation with Low Morbidity and Long Term Disease Free Survival. 2006 ·Blood ·Tsila Zuckerman, Tamar Katz, (unknown), Riva Fineman, Irit Avivi, Eldad J. Dann, Dvora Sahar, (unknown), (unknown), (unknown), Luiza Akria, (unknown), (unknown), Jacob M. Rowe	2
20	Granulocytic sarcoma with pulmonary involvement 2006 ·American Journal of Hematology ·(unknown), Luiza Akria, Eugene Vlodavsky, Jacob M. Rowe	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact